Literature DB >> 28605637

Hepatitis B surface antigen on subviral particles reduces the neutralizing effect of anti-HBs antibodies on hepatitis B viral particles in vitro.

Gustaf E Rydell1, Kasthuri Prakash2, Heléne Norder3, Magnus Lindh4.   

Abstract

During hepatitis B virus (HBV) infections subviral particles (SVP) consisting mainly of hepatitis B surface antigen are present at much higher concentration than viral particles (VP) in serum. To investigate reasons for this excess of SVP production, SVP and VP were fractionated on a Nycodenz gradient and analyzed for HBV infection of HepG2-NTCP cells with and without anti-HBs antibodies. Our findings showed that SVP significantly reduced the neutralization of VP by anti-HBs, while SVP had little effect on viral entry, supporting the assumption that SVP serve as decoy facilitating cell-to-cell spread of HBV in the presence of neutralizing antibodies.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Attachment; Dane particles; HBV; HBsAg; Neutralisation

Mesh:

Substances:

Year:  2017        PMID: 28605637     DOI: 10.1016/j.virol.2017.05.017

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  20 in total

1.  N-Linked Glycosylation Is Not Essential for Sodium Taurocholate Cotransporting Polypeptide To Mediate Hepatitis B Virus Infection In Vitro.

Authors:  Jiwon Lee; Li Zong; Alexander Krotow; Yanli Qin; Lucy Jia; Jiming Zhang; Shuping Tong; Jisu Li
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103

2.  Immune Evasion Strategies Used by Zika Virus to Infect the Fetal Eye and Brain.

Authors:  Branden R Nelson; Justin A Roby; William B Dobyns; Lakshmi Rajagopal; Michael Gale; Kristina M Adams Waldorf
Journal:  Viral Immunol       Date:  2019-11-05       Impact factor: 2.257

Review 3.  Antigen Load and T Cell Function: A Challenging Interaction in HBV Infection.

Authors:  Ilaria Montali; Andrea Vecchi; Marzia Rossi; Camilla Tiezzi; Amalia Penna; Valentina Reverberi; Diletta Laccabue; Gabriele Missale; Carolina Boni; Paola Fisicaro
Journal:  Biomedicines       Date:  2022-05-24

4.  PD-1 blockade partially recovers dysfunctional virus-specific B cells in chronic hepatitis B infection.

Authors:  Loghman Salimzadeh; Nina Le Bert; Charles-A Dutertre; Upkar S Gill; Evan W Newell; Christian Frey; Magdeleine Hung; Nikolai Novikov; Simon Fletcher; Patrick Tf Kennedy; Antonio Bertoletti
Journal:  J Clin Invest       Date:  2018-08-07       Impact factor: 14.808

Review 5.  Current Progress of Virus-mimicking Nanocarriers for Drug Delivery.

Authors:  Masaharu Somiya; Qiushi Liu; Shun'ichi Kuroda
Journal:  Nanotheranostics       Date:  2017-10-31

6.  Circulating and intrahepatic antiviral B cells are defective in hepatitis B.

Authors:  Alice R Burton; Laura J Pallett; Laura E McCoy; Kornelija Suveizdyte; Oliver E Amin; Leo Swadling; Elena Alberts; Brian R Davidson; Patrick Tf Kennedy; Upkar S Gill; Claudia Mauri; Paul A Blair; Nadege Pelletier; Mala K Maini
Journal:  J Clin Invest       Date:  2018-08-09       Impact factor: 19.456

Review 7.  Evolutionary and Structural Overview of Human Picornavirus Capsid Antibody Evasion.

Authors:  Javier Orlando Cifuente; Gonzalo Moratorio
Journal:  Front Cell Infect Microbiol       Date:  2019-08-20       Impact factor: 5.293

8.  High serum levels of pregenomic RNA reflect frequently failing reverse transcription in hepatitis B virus particles.

Authors:  Kasthuri Prakash; Gustaf E Rydell; Simon B Larsson; Maria Andersson; Gunnar Norkrans; Heléne Norder; Magnus Lindh
Journal:  Virol J       Date:  2018-05-15       Impact factor: 4.099

Review 9.  Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms.

Authors:  Joan Kha-Tu Ho; Beena Jeevan-Raj; Hans-Jürgen Netter
Journal:  Viruses       Date:  2020-01-21       Impact factor: 5.048

10.  Extracellular vesicles carry SARS-CoV-2 spike protein and serve as decoys for neutralizing antibodies.

Authors:  Zach Troyer; Najwa Alhusaini; Caroline O Tabler; Thomas Sweet; Karina Inacio Ladislau de Carvalho; Daniela M Schlatzer; Lenore Carias; Christopher L King; Kenneth Matreyek; John C Tilton
Journal:  J Extracell Vesicles       Date:  2021-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.